Splicing Factor Polymorphisms, the Control of VEGF Isoforms and Association with Angiogenic Eye Disease
Autor: | Amanda J. Churchill, J. Cherry, K. J. Williams, David O. Bates, James G. Carter, Steven J. Turner |
---|---|
Rok vydání: | 2011 |
Předmět: |
Adult
Male Vascular Endothelial Growth Factor A Genotype Angiogenesis Pilot Projects Heteroduplex Analysis Retinal Neovascularization Biology Polymerase Chain Reaction Polymorphism Single Nucleotide Macular Degeneration Young Adult Cellular and Molecular Neuroscience Splicing factor chemistry.chemical_compound Exon Humans Protein Isoforms splice Chromatography High Pressure Liquid Aged Aged 80 and over Diabetic Retinopathy Serine-Arginine Splicing Factors Alternative splicing Nuclear Proteins RNA-Binding Proteins Exons Middle Aged Phosphoproteins Molecular biology Choroidal Neovascularization Sensory Systems Vascular endothelial growth factor Alternative Splicing Ophthalmology chemistry Case-Control Studies RNA splicing Female Restriction fragment length polymorphism Polymorphism Restriction Fragment Length |
Zdroj: | Current Eye Research. 36:328-335 |
ISSN: | 1460-2202 0271-3683 |
Popis: | Alternative splicing of the last exon (exon 8) of vascular endothelial growth factor (VEGF) pre-mRNA is a key element in the balance of pro- and anti-angiogenic VEGF isoforms in exudative age-related macular degeneration (exAMD) and proliferative diabetic retinopathy (PDR). Three splicing factors, SRp40, ASF/SF2, and SRp55 are predicted to control alternative splicing by binding to exonic splice enhancers (ESE) in VEGF exon 8. This pilot study examines whether there is an association between angiogenic eye disease and splicing factor polymorphisms, and whether there are sequence variations in the alternative splice sites of the VEGF gene.A case:control pilot study comparing 163 individuals with angiogenic eye disease (94 exAMD and 69 PDR patients) with 95 age-matched controls. Splicing factor polymorphisms were genotyped by Restriction Fragment Length Polymorphism (RFLP) and sequencing, and the VEGF alternatively spliced region was assessed by denaturing High Performance Liquid Chromatography (dHPLC) using a transgenomic WAVE heteroduplex analyzer.No variations were observed in the alternatively spliced region of VEGF exon 8. ASF/SF2 polymorphisms showed no association with exAMD or PDR. For PDR, we observed a trend in SRp40 (rs6573908) where the 5136CC genotype was more frequent in controls (p = 0.0517) and a significant association of the SRp55 (rs2235611), where the 2994C allele was more common in the PDR group (p = 0.03). This remained strong, but not significant, after logistic regression for age, sex, disease type, and duration (p = 0.06).The lack of variation in the VEGF alternatively spliced region suggests the importance of sequence conservation in this area in maintaining the balance of pro- and anti-angiogenic VEGF isoforms. The link between PDR and the SRp55 2994 polymorphism suggests a disease-specific association between factors controlling VEGF splicing and ocular angiogenesis. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |